{"id":97689,"date":"2020-10-26T13:36:18","date_gmt":"2020-10-26T10:36:18","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/oxford-covid-19-vaccine-prompts-immune-response-among-young-elderly\/"},"modified":"2020-10-26T13:36:18","modified_gmt":"2020-10-26T10:36:18","slug":"oxford-covid-19-vaccine-prompts-immune-response-among-young-elderly","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/oxford-covid-19-vaccine-prompts-immune-response-among-young-elderly\/","title":{"rendered":"#Oxford COVID-19 vaccine prompts immune response among young, elderly"},"content":{"rendered":"

“#Oxford COVID-19 vaccine prompts immune response among young, elderly<\/strong>”
\n<\/p>\n

\n A COVID-19 vaccine being developed by Oxford University that is considered a frontrunner in the race for an inoculation against the deadly bug produces a similar immune response among older and younger adults, UK drug maker AstraZeneca said Monday.<\/p>\n

The vaccine\u2019s adverse reactions also were lower among the elderly, the company said, according to Reuters.<\/p>\n

\u201cIt is encouraging to see immunogenicity responses were similar between older and younger adults and that reactogenicity was lower in older adults, where the COVID-19 disease severity is higher,\u201d an AstraZeneca spokesman told the news<\/a> outlet.<\/p>\n

\u201cThe results further build the body of evidence for the safety and immunogenicity of AZD1222,\u201d the rep added, using the scientific name of the vaccine.<\/p>\n

News that older adults get an immune response is encouraging because the immune system weakens with age and older people are those who are most at risk of dying from the disease.<\/p>\n

The Financial Times has reported that the vaccine \u2014 being developed by Oxford and AstraZeneca \u2014 triggers protective antibodies and T-cells among older people, according to Reuters.<\/p>\n

Immunogenicity blood tests performed on older subjects back data released in July that showed the inoculation generated \u201crobust immune responses\u201d in a group of healthy adults between the ages of 18 and 55, the Financial Times reported<\/a>.<\/p>\n

British Health Secretary Matt Hancock said a vaccine is not ready yet, but added that he was preparing logistics for a possible roll out.<\/p>\n

\u201cI would expect the bulk of the roll out to be in the first half of next year,\u201d he told the BBC<\/a>, adding that he was not ruling out the possibility that some people could receive a shot this year.<\/p>\n

\u201cWe want to be ready in case everything goes perfectly but it\u2019s not my central expectation that we\u2019ll be doing that this year, but the program is progressing well, we\u2019re not there yet,\u201d he said.<\/p>\n

Meanwhile, London health officials said staff at a hospital in the capital are on standby to receive the first batches of the vaccine as early as the week beginning Nov. 2, The Sun reported Monday<\/a>.<\/p>\n

Other clinical trials at the unidentified hospital have been paused as all resources have been allocated to preparing to vaccinate thousands of doctors, nurses and other frontline workers, according to the newspaper.\n <\/p><\/div>\n

\n

For forums sites go to Forum.BuradaBiliyorum.Com<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n

\n

If you want to read more News articles, you can visit our News category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n

Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

“#Oxford COVID-19 vaccine prompts immune response among young, elderly” A COVID-19 vaccine being developed by Oxford University that is considered a frontrunner in the race for an inoculation against the deadly bug produces a similar immune response among older and younger adults, UK drug maker AstraZeneca said Monday. The vaccine\u2019s adverse reactions also were lower…<\/p>\n","protected":false},"author":1,"featured_media":97690,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/nypost.com\/wp-content\/uploads\/sites\/2\/2020\/10\/oxford-vaccine-25.jpg?quality=90&strip=all&w=1200","fifu_image_alt":"","footnotes":""},"categories":[70897],"tags":[77174,1545,77192,73840,4966,71041],"class_list":["post-97689","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-10-26-20","tag-coronavirus","tag-oxford-university","tag-pharmaceuticals","tag-united-kingdom","tag-vaccines"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/97689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=97689"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/97689\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/97690"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=97689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=97689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=97689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}